ROBINSON PHARMA
According to U.S. Department of Labor enforcement records, ROBINSON PHARMA — a medicinal and botanical manufacturing facility located at 3330 S. HARBOR BLVD., SANTA ANA, CA 92704 — was the subject of a formal OSHA inspection that resulted in 2 citation(s) and cumulative proposed penalties of $54,000.00. The inspection case was opened on 2017-06-02.
Cumulative penalties significantly exceed the national median for OSHA enforcement actions. The penalty amount suggests multiple high-gravity citations, indicating conditions that presented a substantial probability of death or serious physical harm to employees.
BLS Injury Data: According to the Bureau of Labor Statistics (2022), this industry sector has an occupational injury rate of 3.3 per 100 full-time workers — 22% above the national average of 2.7. The sector fatality rate is 2.3 per 100,000 workers.
EPA Environmental Record: regulated under: Clean Water Act. Source: EPA ECHO database.
Industry Benchmark: The total penalty of $54,000.00 is more than 6.4× the national average of $8,414.32 for facilities in the Manufacturing sector (NAICS 325411). This sector encompasses 52,095 inspected facilities nationwide with aggregate penalties totaling $438.3M.
State Context: Within CA, this facility's penalty places it at the 100th percentile among 184,062 inspected facilities. The statewide average penalty is $3,010.44.
Citation Analysis: The inspection produced 2 citations spanning 0 distinct OSHA regulatory standards. The citation breakdown includes: 1 repeat — A substantially similar violation was found during a previous inspection and the original citation has become a final order. 1 serious — A workplace hazard that could cause death or serious physical harm exists, and the employer knew or should have known about the condition.
Enforcement Timeline: Citations were issued beginning August 14, 2017 with the latest abatement deadline set for August 28, 2017. Of the 2 total citations, 0 (0%) have been marked as abated in DOL records, which may indicate ongoing compliance gaps requiring further regulatory attention.
Penalty Assessment: The per-citation average of $27,000.00 exceeds OSHA's FY2024 statutory maximum of $16,131 for serious violations, indicating the presence of willful or repeat classifications that carry enhanced penalty authority under Section 17 of the OSH Act.
Robinson Pharma’s 2017 enforcement record revealed a troubling intersection of systemic management failures and high
This facility's $54,000 penalty is higher than 99% of all penalized companies in the NAICS 325411 industry in CA. The state average penalty for this industry is $6,421.
Comparing penalized facilities in SANTA ANA, CA (Broader Sector)
Explore more: OSHA enforcement in SANTA ANA · California data · Search the database · Incident Rate Calculator
What OSHA violations was ROBINSON PHARMA cited for?
ROBINSON PHARMA received 2 citation(s) covering 0 distinct OSHA standards. Total proposed penalties were $54,000.00. The inspection opened on 2017-06-02.
How much was ROBINSON PHARMA fined by OSHA?
OSHA proposed penalties of $54,000.00 against ROBINSON PHARMA in SANTA ANA, CA. Average per citation: $27,000.00.
Is ROBINSON PHARMA a safe workplace?
Based on enforcement records, ROBINSON PHARMA has a risk score of 26 out of 100. Cumulative penalties significantly exceed the national median for OSHA enforcement actions. The penalty amount suggests multiple high-gravity citations, indicating conditions that presented a substantial probability of death or serious physical harm to employees.
How does this penalty compare to the industry average?
The average penalty for Medicinal and Botanical Manufacturing facilities is $8,414.32. This facility penalty of $54,000.00 is above the industry average.